FDA says companies selling dynamic-stabilization system must collect clinical data – DePuy, Medtronic and Zimmer are named

The U.S. Food and Drug Administration said Monday that companies making or hoping to sell so-called dynamic-stabilization systems for spinal surgery must run studies to collect data on "a number of potential safety issues." 2nd UPDATE: FDA Orders Studies On Spinal Devices  (NASDAQ)...  http://ow.ly/sViS...